Yusen expands collaborative pharma network servicing final mile distribution throughout Europe
Posted: 23 June 2015 | Yusen Logistics
The expanded service manages in-market supply to end users – hospitals, pharmacies, doctors, dentists, wholesalers, vaccination centres in 8 countries initially: Austria, Denmark, France, Italy, Spain, UK, Germany, Belgium, and Poland expected to follow later in the year.
Healthcare manufacturers are increasingly searching for innovative end-to-end solutions to move their products throughout the supply chain, whilst maintaining a stringent temperature regime at all times. Maximising availability of stock, whilst minimising risk in the supply chain are driving the growing demand.
This service is dedicated solely to the stringent requirements of the pharmaceutical and healthcare industry, with over 50,000 delivery points. Yusen currently makes 20,000 deliveries per week across 36 countries.
The Control Tower managed Yusen network offers huge benefits to the customers, with stringent management of the in-market transport providers and the ability to maximise economies of scale in the purchase of the best in-market freight lanes.
The operation drives common standards, optimising quality and compliance to drive towards complete assurance of supply. Yusen’s IT infrastructure enables audit and approval of every carrier to drive standards in line with GDP regulations. Centralised data management also enables customers to benefits from single invoicing.
Yusen Logistics General Manager Healthcare, Matthew Ray explains:
“This innovation gives Yusen a unique position across the pharmaceutical supply chain, offering a complete end-to-end service from raw material to patients across the whole of Europe.
Yusen’s European Pharmaceutical Superhighway is already contracted to carry over 1.6million pallets this year. Growth is set to continue as more manufacturers buy into its high security services including cross border, temperature controlled coverage, with flexible GDP compliant solutions, ensuring complete product integrity and legislative compliance.”
